Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han population

Clinical Immunology

Volumn 136, Issue 3, 2010, Pages 442-446

  Chen, Chao ^a   Zhang, Xuesong ^a   Wang, Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Ankylosing spondylitis; Janus kinase 2; Polymorphism; Signal transducer and activator of transcription 3

Indexed keywords

CYSTEINE; GLYCINE; INTERLEUKIN 23; JANUS KINASE 2; STAT3 PROTEIN; THREONINE;

ADOLESCENT; ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL;

EID: 77955270391     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.05.003     Document Type: Article

References (27)

1. Reveille J.D., Ball E.J., Khan M.A. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr. Opin. Rheumatol. 2001, 13:265-272.
2. Reveille J.D. Recent studies on the genetic basis of ankylosing spondylitis. Curr. Rheumatol. Rep. 2009, 11:340-348.
3. Burton P.R., Clayton D.G., Cardon L.R., et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 2007, 39:1329-1337.
4. Karaderi T., Harvey D., Farrar C., et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009, 48:386-389.
5. Rahman P., Inman R.D., Gladman D.D., Reeve J.P., Peddle L., Maksymowych W.P. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 2008, 58:1020-1025.
6. Rueda B., Orozco G., Raya E., et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 2008, 67:1451-1454.
7. Layh-Schmitt G., Colbert R.A. The interleukin-23/interleukin-17 axis in spondyloarthritis. Curr. Opin. Rheumatol. 2008, 20:392-397.
8. Gaffen S.L. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr. Rheumatol. Rep. 2009, 11:365-370.
9. Shen H., Goodall J.C., Gaston J.S.H. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009, 60:1647-1656.
10. Sato K., Suematsu A., Okamoto K., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
11. Wang X., Lin Z., Wei Q., Jiang Y., Gu J. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol. Int. 2009, 29:1343-1347.
12. Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40:955-962.
13. Anderson C.A., Massey D.C., Barrett J.C., et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009, 136:523-529.e3.
14. Franke A., Balschun T., Karlsen T.H., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 2008, 40:713-715.
15. Colombo E., Latiano A., Palmieri O., Bossa F., Andriulli A., Annese V. Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?. World J. Gastroenterol. 2009, 15:2456-2462.
16. van der Linden S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27:361-368.
17. Kim T.J., Kim T.H., Lee H.J., et al. Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea. J. Rheumatol. 2008, 35:1603-1608.
18. Stepkowski S.M., Chen W., Ross J.A., Nagy Z.S., Kirken R.A. STAT3: an important regulator of multiple cytokine functions. Transplantation 2008, 85:1372-1377.
19. Chen Z., Laurence A., O'Shea J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 2007, 19:400-408.
20. Fischer A. Human immunodeficiency: connecting STAT3, Th17 and human mucosal immunity. Immunol. Cell Biol. 2008, 86:549-551.
21. Safrany E., Pazar B., Csongei V., et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Scand. J. Immunol. 2009, 70:68-74.
22. Saleh A., Shan L., Halayko A.J., Kung S., Gounni A.S. Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells. J. Immunol. 2009, 182:3357-3365.
23. Abraham C., Cho J.H. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2009, 60:97-110.
24. Parham C., Chirica M., Timans J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002, 168:5699-5708.
25. Lees C.W., Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev. Gastroenterol. Hepatol. 2009, 3:513-534.
26. Thomas G.P., Brown M.A. Genetics and genomics of ankylosing spondylitis. Immunol. Rev. 2010, 233:162-180.
27. Davidson S.I., Wu X., Liu Y., et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 2009, 60:3263-3268.